§ 13F · FUND PROFILE
Lynx1 Capital Management LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $491M (13F)Positions · 14Turnover · — · Q1Filed · May 4, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$1M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 4, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | STOK | STOKE THERAPEUTICS INC | 4.76M | $155M | 24.5% | −12% |
| 2 | GHRS | GH RESEARCH PLC | 10.76M | $151M | 23.9% | +3% |
| 3 | CGEM | CULLINAN THERAPEUTICS INC | 8.96M | $127M | 20.1% | ±0% |
| 4 | AGIO | AGIOS PHARMACEUTICALS INC | 2.61M | $88M | 14.0% | +3180% |
| 5 | DNLI | DENALI THERAPEUTICS INC | 1.88M | $36M | 5.7% | +8% |
| 6 | CCCC | C4 THERAPEUTICS INC | 7.00M | $18M | 2.9% | −1% |
| 7 | KRRO | KORRO BIO INC | 1.54M | $17M | 2.8% | +127% |
| 8 | TCRX | TSCAN THERAPEUTICS INC | 8.02M | $8M | 1.3% | ±0% |
| 9 | XNCR | XENCOR INC | 536K | $6M | 1.0% | −24% |
| 10 | DTIL | PRECISION BIOSCIENCES INC | 985K | $5M | 0.9% | −1% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE LYNX1 SIGNAL
AC read
Lynx1 Capital Management LP is a Other fund managing $491 million in assets. The fund runs a focused portfolio of just 14 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
2 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed